Nana Wu

Beyond the Pink Ribbon: Angela Hernandez’s Journey Through Diagnosis, Advocacy, and the Reality of Breast Cancer Survival

• Patient Advocacy and Support

Beyond the Pink Ribbon: Angela Hernandez’s Journey Through Diagnosis, Advocacy, and the Reality of Breast Cancer Survival

Nana Wu September 19, 2026

Main Facts: A Life Altered at Forty At the age of 40—a milestone often associated with the...

Read More Read more about Beyond the Pink Ribbon: Angela Hernandez’s Journey Through Diagnosis, Advocacy, and the Reality of Breast Cancer Survival

Skyhawk Therapeutics Advances RNA-Splicing Frontier: Long-Term Data Bolsters Case for SKY-0515 in Huntington’s Disease

• Chemotherapy and Targeted Therapy

Skyhawk Therapeutics Advances RNA-Splicing Frontier: Long-Term Data Bolsters Case for SKY-0515 in Huntington’s Disease

Nana Wu September 18, 2026

By Jacob Bell Published September 16, 2026 In the high-stakes arena of neurodegenerative drug development, few companies...

Read More Read more about Skyhawk Therapeutics Advances RNA-Splicing Frontier: Long-Term Data Bolsters Case for SKY-0515 in Huntington’s Disease

Sling Therapeutics Secures $123M to Advance Oral Treatment for Thyroid Eye Disease

• Treatment Innovations

Sling Therapeutics Secures $123M to Advance Oral Treatment for Thyroid Eye Disease

Nana Wu September 18, 2026

In a significant milestone for ophthalmology and autoimmune research, Ann Arbor-based biotechnology startup Sling Therapeutics has announced...

Read More Read more about Sling Therapeutics Secures $123M to Advance Oral Treatment for Thyroid Eye Disease

Precision Oncology in Renal Cell Carcinoma: Exploring Adaptive Treatment Strategies with Pembrolizumab and Axitinib

• Clinical Oncology Education

Precision Oncology in Renal Cell Carcinoma: Exploring Adaptive Treatment Strategies with Pembrolizumab and Axitinib

Nana Wu September 18, 2026

The landscape of renal cell carcinoma (RCC) treatment is undergoing a fundamental transformation. As clinicians move away...

Read More Read more about Precision Oncology in Renal Cell Carcinoma: Exploring Adaptive Treatment Strategies with Pembrolizumab and Axitinib

Global Health Sovereignty: The High-Stakes Race for a Binding Pandemic Treaty

• Global Breast Cancer Awareness

Global Health Sovereignty: The High-Stakes Race for a Binding Pandemic Treaty

Nana Wu September 18, 2026

In a decisive move at the World Health Organization (WHO) headquarters in Geneva, member states have reaffirmed...

Read More Read more about Global Health Sovereignty: The High-Stakes Race for a Binding Pandemic Treaty

The Anatomy of Resilience: Sally Dallas and the Literary Landscape of Cancer Survivorship

• Psychosocial Support and Mental Health

The Anatomy of Resilience: Sally Dallas and the Literary Landscape of Cancer Survivorship

Nana Wu September 17, 2026

Introduction: The Unseen Adversary Cancer is often described in the metaphors of war—a "battle" against an "invader."...

Read More Read more about The Anatomy of Resilience: Sally Dallas and the Literary Landscape of Cancer Survivorship

A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

• Medical Research and Clinical Trials

A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

Nana Wu September 17, 2026

New York, NY – January 22, 2024 – In a significant breakthrough poised to redefine the landscape...

Read More Read more about A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

A New Era for Global Health: African Nations Lead Historic Funding Drive for the WHO

• Global Breast Cancer Awareness

A New Era for Global Health: African Nations Lead Historic Funding Drive for the WHO

Nana Wu September 17, 2026

In a landmark display of multilateral cooperation, 14 African nations and a coalition of global philanthropic partners...

Read More Read more about A New Era for Global Health: African Nations Lead Historic Funding Drive for the WHO

Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

• Treatment Innovations

Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

Nana Wu September 16, 2026

By Jonathan Gardner | Published September 14, 2026 In a decisive move that signals a fundamental retreat...

Read More Read more about Pivot Point: Cellectis Abandons Allogeneic Cell Therapy Ambitions for Cardiovascular Gene Editing

The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

• Breast Cancer Surgery and Reconstruction

The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

Nana Wu September 16, 2026

For patients navigating a breast cancer diagnosis, the medical journey is fraught with physical, emotional, and psychological...

Read More Read more about The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates